The University of Texas Medical Branch (UTMB) at Galveston offers a training program in Allergy and Clinical Immunology, which is fully accredited by the American Medical Association Liaison Committee on Graduate Medical Education. This is a conjoint program offered by the Allergy & Immunology Division of the Department of Internal Medicine and the Division of Infectious Diseases and Immunology of the Department of Pediatrics.
UTMB is the oldest medical school in Texas and the second oldest in the western states. The UTMB complex consists of integrated schools of medicine, graduate biomedical sciences, allied health sciences, and nursing. The core faculty for this program within the Departments of Internal Medicine and Pediatrics includes eight full-time physicians board-certified in Allergy and Immunology. The faculty has received regional, national, and international recognition for accomplishments in patient care, education, and medical research. Our program is the home of the NHLBI Proteomics Center, the NIEHS Environmental Health Center, the Child Health Research Center and the Institute for Translational Science funded by the NIH Institutional Clinical Translational Science Award (ICTSA). These facilities serve as critical parts of the Allergy and Immunology Residency Program.
Generally, physicians will be accepted for this program who have completed their training in Internal Medicine or Pediatrics and are board eligible, and after completion of this program can apply for certification by the American Board of Allergy and Immunology. A wide variety of opportunities is available for training in clinical medicine, as well as laboratory research, and all clinical fellows will be expected to participate in both of these spheres over the course of the fellowship. Fellows may elect to stay an additional one or two years to complete research training in preparation for a career in academic medicine. The program also recruits graduate students training for a PhD in microbiology-immunology and research fellows. These trainees provide additional resources for physicians training in the program.
Started in 1970, UTMB is one of the oldest programs in Allergy and Immunology in the country. The objective of the training program is to provide advanced education in basic immunology, comprehensive training in allergy and clinical immunology, and laboratory training in basic and clinical research. UTMB has had a nearly 100% pass rate in the American Board of Allergy and Immunology certifying exam for the last 10 years. In addition, it has produced the next generation of thought leaders such as Dr. Kay Horner (Assistant Professor, Washington University), Dr. Yoshiko Ogawa (Assistant Professor, BCM), Dr. Rana Bonds and Dr. George Brown (Assistant Professors at UTMB).
The overall goals and objectives of the educational program can be divided into four categories : clinical, didactic, research, and mentoring programs.
The UTMB Center for Global Health Education (CGHE) is dedicated to the training of tomorrow's global health work force to improve health for the people of Texas and around the world. Check out their website for more information on the global health programs and education going on in our department.
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.Currently available protocols are:
- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.